![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Dr. Reddy\'s Laboratories (1)
02 Taro Pharmaceutical Industries (2)
03 Breckenridge Pharmaceutical (1)
04 NanoAlvand (2)
05 Ajanta Pharma Limited (1)
06 Auro Pharma Inc (2)
07 Aurobindo Pharma Limited (1)
08 Bluepharma (2)
09 DelNova Healthcare (3)
10 Farmaprojects S.A.U (3)
11 Hikma Pharmaceuticals (1)
12 Intas Pharmaceuticals (2)
13 JAMP PHARMA (1)
14 Laboratorio Eczane Pharma (2)
15 MSN Laboratories (2)
16 Micro Labs Limited (1)
17 Pfizer Consumer Healthcare (17)
18 Pfizer Inc (10)
19 Pharmascience Inc. (1)
20 Pluviaendo (3)
21 Prinston (1)
22 Pulse Pharmaceuticals (2)
23 Unichem Laboratories Limited (1)
24 Yaopharma (2)
25 Zydus Pharmaceuticals (3)
01 Extended Release Tablet (3)
02 FCT (1)
03 Film Coated Tablet (3)
04 Film Coated XR Tablet (1)
05 Film Tablet (1)
06 IR Film Coated Tablet (2)
07 Oral Solid Dosage Form (1)
08 Oral Solution (1)
09 SOLUTION;ORAL (2)
10 SR Tablet (2)
11 Sustained Release Tablet (1)
12 TABLET (8)
13 TABLET (EXTENDED-RELEASE) (1)
14 TABLET, EXTENDED RELEASE;ORAL (5)
15 TABLET;ORAL (11)
16 Tablet (7)
17 tablet (12)
18 Blank (5)
01 DISCN (6)
02 Generic (1)
03 Lead Market Dossiers- Under Development (1)
04 Originator (1)
05 Prescription (9)
06 RX (6)
07 Blank (43)
01 AURO-TOFACITINIB (2)
02 JAMP TOFACITINIB (1)
03 PMS-TOFACITINIB (1)
04 Rhofanib (2)
05 TARO-TOFACITINIB (2)
06 TOFACITINIB (7)
07 TOFACITINIB CITRATE (4)
08 Tofacitinib (2)
09 Tofax (2)
10 Tofaxen 11 XR (1)
11 Tofaxen 5 (1)
12 XELJANZ (5)
13 XELJANZ XR (5)
14 Xeljanz (18)
15 Xeljanz 5 mg (1)
16 Blank (13)
01 Argentina (2)
02 Australia (17)
03 Canada (9)
04 India (9)
05 Iran (2)
06 Portugal (2)
07 South Africa (1)
08 Spain (3)
09 Switzerland (1)
10 Turkey (3)
11 USA (18)